Name | Type | Posted | Actions |
|---|---|---|---|
Amendment_5to_the_RFP_-_10-18-2024_0005.pdf | Oct 18, 2024 | ||
Amendment_4_to_the_RFP_-_10-11-2024_0004.pdf | Oct 11, 2024 | ||
Amendment_3_to_the_RFP_-_10-08-2024_0003.pdf | Oct 8, 2024 | ||
Amendment_2_to_the_RFP_-_9-20-24_0002.pdf | Sep 20, 2024 | ||
Amendment_1_to_RFP_75N94024R00008_9-11-24_0001.pdf | Sep 11, 2024 | ||
Sol_75N94024R00008.pdf | Sep 4, 2024 |
A--BPCA Pediatric Trials Network
Contact and place of performance
OSINSKI, ELIZABETH J
Not specified
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
The National Institutes of Health, specifically the National Institutes of Health NICHD, is issuing solicitation 75N94024R00008 to support the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN). This requirement falls under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC code AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. The project focuses on pediatric clinical trials and related research and development services to support the objectives of the BPCA.
Responses to this solicitation are due by November 4, 2024. Elizabeth J. Osinski is the designated point of contact for this notice, which was first published on September 4, 2024, and last updated on October 18, 2024. The solicitation documentation includes six total attachments: the initial solicitation file posted on September 4, 2024, and five subsequent amendments issued on September 11, September 20, October 8, October 11, and October 18, 2024.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.